InvestorsHub on MSN
Entera Bio names former Pfizer executive Geno Germano as board chair
Entera Bio Ltd. (NASDAQ:ENTX) has appointed seasoned pharmaceutical executive Geno J. Germano as Chairman of the Board, effective February 4, 2026, as the company approaches several key clinical ...
Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced ...
By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...
PRINCETON, N.J., Feb. 25, 2026 /PRNewswire/ -- Hoot Health today announced its entry into the pharmaceutical market with an AI-powered, physician-led patient education engine designed to address one ...
The MarketWatch News Department was not involved in the creation of this content. TEL AVIV, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in ...
TEL AVIV, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results